Q4 Top Performers: Vita Coco (NASDAQ:COCO) and Other Leading Beverage, Alcohol, and Tobacco Stocks

Q4 Earnings Overview: Beverage, Alcohol, and Tobacco Sector

As the fourth quarter earnings season concludes, we examine the financial results and main insights for beverage, alcohol, and tobacco companies, including Vita Coco (NASDAQ:COCO) and its industry counterparts.

The success of these businesses is shaped by factors such as brand reputation, marketing efforts, and evolving consumer tastes. Notably, shifts in consumption—like the growing popularity of cannabis, craft beer, and vaping, alongside the ongoing decline in soda and cigarette use—are reshaping the market. Companies that prioritize innovation and adapt to emerging trends often see increased demand, while those slow to respond may experience stagnant sales. Additionally, social media has lowered the barriers to launching new brands, allowing newcomers to gradually erode the market share of established firms.

Sector Performance in Q4

Among the 13 beverage, alcohol, and tobacco stocks tracked, the group delivered a solid fourth quarter. Collectively, their revenues surpassed analyst forecasts by 2.1%, and guidance for the upcoming quarter was generally in line with expectations.

Despite these positive results, share prices have struggled, with the group’s average stock price declining 5.5% since the latest earnings announcements.

Vita Coco (NASDAQ:COCO) Highlights

Established in 2004 and publicly listed in 2021, The Vita Coco Company (NASDAQ:COCO) specializes in coconut water products, offering a natural hydration option.

For the quarter, Vita Coco posted $127.8 million in revenue, matching last year’s performance but exceeding analyst estimates by 6.2%. The company notably outperformed expectations for both EBITDA and adjusted operating income, marking a standout quarter.

Vita Coco Total Revenue

However, Vita Coco issued the most cautious full-year outlook among its peers. Reflecting this, the stock has fallen 6.2% since the earnings release and is currently trading at $52.99.

Top Q4 Performer: Celsius (NASDAQ:CELH)

Celsius (NASDAQ:CELH) is known for its energy drinks, which feature the proprietary MetaPlus formula and natural ingredients aimed at supporting fitness and weight management.

In the fourth quarter, Celsius generated $721.6 million in revenue—a remarkable 117% increase year-over-year—beating analyst projections by 13.5%. The company also exceeded expectations for both EBITDA and revenue, delivering an outstanding quarter.

Celsius Total Revenue

Celsius led its peer group in both revenue growth and beating analyst estimates. Despite these achievements, the stock has dropped 13% since the earnings report and is now priced at $44.06.

Q4 Laggard: Altria (NYSE:MO)

Altria (NYSE:MO), best recognized for its Marlboro cigarette brand, offers a range of tobacco and nicotine products.

Altria’s quarterly revenue was $5.08 billion, unchanged from the previous year but slightly above analyst expectations by 1.1%. However, the company missed estimates for both EBITDA and adjusted operating income, making for a slower quarter.

Interestingly, Altria’s stock has risen 6.9% since the earnings announcement and is currently valued at $67.49.

Constellation Brands (NYSE:STZ) Update

Operating in over 100 countries, Constellation Brands (NYSE:STZ) is a leading global producer and marketer of beer, wine, and spirits.

Constellation Brands reported $2.22 billion in revenue for the quarter, a 9.8% decrease from the prior year, but still 2.9% above analyst forecasts. The company also delivered strong results for both EBITDA and organic revenue, outperforming expectations.

The stock has appreciated 4.8% since the earnings release and is now trading at $147.30.

Keurig Dr Pepper (NASDAQ:KDP) Insights

Keurig Dr Pepper (NASDAQ:KDP) was created through the 2018 merger of Keurig Green Mountain and Dr Pepper Snapple, forming a major player in the beverage sector with a diverse lineup of sodas, coffees, and juices.

The company posted $4.50 billion in revenue for the quarter, a 10.5% year-over-year increase and 3.1% above analyst estimates. While Keurig Dr Pepper exceeded revenue expectations, it fell short on gross margin estimates, resulting in a mixed quarter.

Since the earnings report, the stock has declined 5.3% and currently trades at $28.19.

Looking for High-Quality Investments?

If you’re seeking companies with strong fundamentals, explore our Top 5 Quality Compounder Stocks—these businesses are well-positioned for growth, regardless of economic or political changes.

The StockStory analyst team, comprised of experienced professional investors, leverages quantitative analysis and automation to deliver timely, high-quality market insights.